Cargando…

Medical students as junior adverse drug event managers facilitating reporting of ADRs

The Junior Adverse Drug Event Manager (J‐ADEM) team is a multifaceted intervention focusing on real‐life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected adverse drug reactions (ADRs) to the Netherlands Pharmacovigilance Centre...

Descripción completa

Detalles Bibliográficos
Autores principales: Reumerman, Michael O., Tichelaar, Jelle, Richir, Milan C., van Agtmael, Michiel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291906/
https://www.ncbi.nlm.nih.gov/pubmed/33955031
http://dx.doi.org/10.1111/bcp.14885
_version_ 1784749241702285312
author Reumerman, Michael O.
Tichelaar, Jelle
Richir, Milan C.
van Agtmael, Michiel A.
author_facet Reumerman, Michael O.
Tichelaar, Jelle
Richir, Milan C.
van Agtmael, Michiel A.
author_sort Reumerman, Michael O.
collection PubMed
description The Junior Adverse Drug Event Manager (J‐ADEM) team is a multifaceted intervention focusing on real‐life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected adverse drug reactions (ADRs) to the Netherlands Pharmacovigilance Centre Lareb. The aim of this study was to quantify and describe the ADRs reported by the J‐ADEM team and to determine the clinical potential of this approach. The J‐ADEM team consisted of medical students tasked with managing and reporting ADRs in hospitalized patients. All ADRs screened and reported by J‐ADEM team were recorded anonymously, and categorized and analysed descriptively. From August 2018 through January 2020, 209 patients on two wards in an academic hospital were screened for ADR events. The J‐ADEM team reported 101 ADRs. Although most ADRs (67%) were first identified by healthcare professionals and then reported by the J‐ADEM team, the team also reported an additional 33 not previously identified serious ADRs. In 10% of all reported ADRs, the J‐ADEM team helped optimize ADR treatment. The ADR reports were largely well‐documented (78%), and ADRs were classified as type A (66%), had a moderate or severe severity (85%) and were predominantly avoidable reactions (69%). This study shows that medical students are able to screen patients for ADRs, can identify previously undetected ADRs and can help optimize ADR management. They significantly increased (by 300%) the number of ADR reports submitted, showing that the J‐ADEM team can make a valuable clinical contribution to hospital care.
format Online
Article
Text
id pubmed-9291906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92919062022-07-20 Medical students as junior adverse drug event managers facilitating reporting of ADRs Reumerman, Michael O. Tichelaar, Jelle Richir, Milan C. van Agtmael, Michiel A. Br J Clin Pharmacol Short Reports The Junior Adverse Drug Event Manager (J‐ADEM) team is a multifaceted intervention focusing on real‐life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected adverse drug reactions (ADRs) to the Netherlands Pharmacovigilance Centre Lareb. The aim of this study was to quantify and describe the ADRs reported by the J‐ADEM team and to determine the clinical potential of this approach. The J‐ADEM team consisted of medical students tasked with managing and reporting ADRs in hospitalized patients. All ADRs screened and reported by J‐ADEM team were recorded anonymously, and categorized and analysed descriptively. From August 2018 through January 2020, 209 patients on two wards in an academic hospital were screened for ADR events. The J‐ADEM team reported 101 ADRs. Although most ADRs (67%) were first identified by healthcare professionals and then reported by the J‐ADEM team, the team also reported an additional 33 not previously identified serious ADRs. In 10% of all reported ADRs, the J‐ADEM team helped optimize ADR treatment. The ADR reports were largely well‐documented (78%), and ADRs were classified as type A (66%), had a moderate or severe severity (85%) and were predominantly avoidable reactions (69%). This study shows that medical students are able to screen patients for ADRs, can identify previously undetected ADRs and can help optimize ADR management. They significantly increased (by 300%) the number of ADR reports submitted, showing that the J‐ADEM team can make a valuable clinical contribution to hospital care. John Wiley and Sons Inc. 2021-05-26 2021-12 /pmc/articles/PMC9291906/ /pubmed/33955031 http://dx.doi.org/10.1111/bcp.14885 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Short Reports
Reumerman, Michael O.
Tichelaar, Jelle
Richir, Milan C.
van Agtmael, Michiel A.
Medical students as junior adverse drug event managers facilitating reporting of ADRs
title Medical students as junior adverse drug event managers facilitating reporting of ADRs
title_full Medical students as junior adverse drug event managers facilitating reporting of ADRs
title_fullStr Medical students as junior adverse drug event managers facilitating reporting of ADRs
title_full_unstemmed Medical students as junior adverse drug event managers facilitating reporting of ADRs
title_short Medical students as junior adverse drug event managers facilitating reporting of ADRs
title_sort medical students as junior adverse drug event managers facilitating reporting of adrs
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291906/
https://www.ncbi.nlm.nih.gov/pubmed/33955031
http://dx.doi.org/10.1111/bcp.14885
work_keys_str_mv AT reumermanmichaelo medicalstudentsasjunioradversedrugeventmanagersfacilitatingreportingofadrs
AT tichelaarjelle medicalstudentsasjunioradversedrugeventmanagersfacilitatingreportingofadrs
AT richirmilanc medicalstudentsasjunioradversedrugeventmanagersfacilitatingreportingofadrs
AT vanagtmaelmichiela medicalstudentsasjunioradversedrugeventmanagersfacilitatingreportingofadrs